NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Press
Release
SHL Group, a world leader in device design and manufacturing, is proud to be participating in the 2018 BIO International Convention in Boston, Massachusetts from June 4-7.
SHL will be at Booth #2525 to show its range of patient-friendly drug delivery solutions, which can accommodate any formulation for subcutaneous and intramuscular injection: low viscosity, high viscosity, high volume, unstable, and more.
Representatives will also be on-site to introduce SHL’s turnkey solution, which leverages a full suite of in-house capabilities to take clients from device design to finished product distribution.
Drawing over 16,000 participants from 5,000 companies last year, BIO International Convention is a premier biotech convention for industry partnering, education, and networking. SHL looks forward to connecting with top biotech and pharma companies and helping them meet their clinical and commercial needs.
To learn more about our offering, visit at Booth #2525 at the Boston Convention & Exhibition Center.